Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 19.01 crore in Q1FY24, growth of 26.66% Y-o-Y
Financial Report | 11/08/2023 | By Sudeep Soparkar | 373
BAL Pharma posts Rs 700.71 M revenue for Q1FY23
Revenue was impacted by macro and uncontrolled factors led by geopolitical concerns, external market turmoil and certain other unavoidable market factors
Financial Report | 16/08/2022 | By Sudeep Soparkar | 430
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy